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SUMMARY 
Opiate alkaloid and opioid peptide actions on spontaneous neuronal activity 
and postsynaptic amino acid responsiveness were assessed using intracellular record- 
ing techniques applied to murine spinal cord neurons in primary dissociated cell 
culture. Application of  opiates was by superfusion and amino acids by iontophoresis. 
Glycine and GABA but not glutamate responses were antagonized by the opiate 
alkaloids. Since opiate effects on glycine and GABA responses were not naloxone- 
reversible, only weakly stereospecific, and not produced by the opioid peptide [D- 
Ala2]-Met-enkephalinamide, it is unlikely that these effects were mediated by opiate 
recep:ors. Opiate depression of  glycine inhibition was correlated with the induction of 
paroxysmal depolarizations in cultured spinal cord neurons, suggesting that antago- 
nism of inhibitory amino acid transmission may underlie the convulsant actions of 
high concentrations of the opiate alkaloids. 
INTRODUCTION 
Accumulating evidence indicates that opiates have several distinct inhibitory 
actions, including presynaptic depression of transmitter release25, 8°,36, direct post- 
synaptic hyperpolarization38, 39 and postsynaptic antagonism of amino acid re- 
sponses6,14-16, 2s,53,55. In addition, opiates have been reported to have excitatory 
actions6,11,1~, ~1. While several of these actions might be attributable to activation of 
different classes of opiate receptor, others might be non-specific, involving interaction 
with sites other than opiate receptors. 
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Included among the excitatory actions of opiates is the production of convul- 
sions by the opiate alkaloids 13,14,2°,41,47,48 and peptides 19,2°,46,4s. it is unclear if 
opiate induction of seizures is mediated by opiate receptors, since large concentrations 
of morphine are required 2°,47,4s and the resultant seizures are resistant to naloxone 
antagonism20,31, 48. The mechanism of opiate epileptogenesis is also unclear, but two 
mechanisms have been proposed : (1) presynaptic depression of GABA release4,37, 54 
and (2) postsynaptic modulation of amino acid responsiveness6,14. 
Opiates have been reported to antagonize glycine6,11,12,15,16,2s, GABA 14-16 and 
glutamate~5-~7,23,53, 55 effects on neuronal firing rate. Opiate antagonism of glycine- 
and GABA-induced inhibition of neuronal firing has generally not been naloxone 
reversibleS2, ~6, suggesting the effect is not mediated by opiate receptors. Indeed, an 
interaction with glycine and GABA receptors rather than opiate receptors is likely, 
since the opiate alkaloids have been reported to displace [ZH]strychnine and [ZH]- 
GABA bound to synaptic membranes14,sL In contrast, glutamate-induced firing has 
been reported to be depressed by opiates in a stereospecific 53 and naloxone rever- 
sibleS7,23,53, ~5 manner, suggesting an opiate receptor mediated effect. However, 
naloxone did not reverse opiate depression of glutamate responses in several other 
studies16,1s,45. 
We investigated opiate actions on spontaneous neuronal activity and post- 
synaptic amino acid responsiveness using intraceilular recording techniques applied to 
murine spinal cord neurons in primary dissociated cell culture. We report that 
morphine antagonized postsynaptic glycine and GABA but not glutamate responses. 
Antagonism of glycine responses was correlated with the induction of paroxysmal 
depolarizations in cultured spinal cord neurons. Morphine actions on postsynaptic 
inhibitory amino acid responsiveness and spontaneous activity were not mediated by 
opiate receptors since the effects were not naloxone reversible, stereospecific, or 
produced by the opioid peptide [D-Ala~]-Met-enkephalinamide. 
MATERIALS AND METHODS 
Cell culture 
Neuronal cultures were prepared by dissecting spinal cords with attached dorsal 
root ganglia from 12-14-day-old fetal mice 43. The tissue was mechanically dissociated 
to a single cell suspension which was plated on 35 mm collagen-coated culture plates at 
a density of 1/4 to 1/2 spinal cord per plate. Initial culture medium consisted of 80 
Eagle's minimum essential medium, 10~ horse serum, and 10~ fetal calf serum. 
Approximately 4 days after initial plating, 5'-fluoro-2'-deoxyuridine and uridine were 
added to the cultures to inhibit the division of non-neuronal background cells after 
which growth medium was modified to 90 ~ Eagle's minimum essential medium and 
10~ horse serum. Four-to-twelve-week-old cultures were used in electrophysio- 
logical experiments. 
Intracellular recording 
For electrophysiological studies, cultures were placed on the heated stage (35 °C) 
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of an inverted phase contrast microscope which allowed neuronal impalement by a 
recording electrode under visual control. Intracellular recordings were obtained using 
4 M potassium acetate or 3 M potassium chloride filled micropipettes which had a 
resistance of 25-50 MfL A modified bridge circuit allowed simultaneous current 
passage and voltage recording by single microelectrodes. Data were recorded on a 6- 
channel polygraph. 
Prior to recording of spontaneous electrical activity, growth medium was poured 
from the culture and replaced by Dulbecco's phosphate-buffered saline (DPBS). A thin 
coat of mineral oil over the DPBS retarded evaporation. Recordings were obtained 
from each culture over a 3 h period. The initial hour consisted of recording 
spontaneous activity in control medium. At the end of both the first and second hours, 
opiates were added to the culture using a microliter pipetter. Five to ten neurons were 
impaled during each hour. 
lontophoresis of amino acids during superfusion 
Experiments were performed in DPBS containing 10 mM magnesium ion to 
suppress spontaneous activity. GABA, glycine and glutamate (all 0.5 M ; pH 3.2, 1.8, 
and 9.1, respectively) were applied by iontophoresis using constant current pulses (500 
ms) of 0-40 nA. 
Morphine (Mallinckrodt), levorphanol and dextrorphan (Hoffmann-LaRoche), 
naloxone (Endo Laboratories), and [o-Ala2]-Met-enkephalinamide (Calbiochem) 
were superfused through the culture at a rate of 0.6 ml/min by a peristaltic pump. 
Neurons were impaled in control medium, the peristaltic pump was started and the 
superfusion rate was then unaltered for the duration of the recording. Iontophoretic 
current was adjusted to obtain amino acid responses of 10-20 mV in control medium 
with responses evoked every 0.5-1.0 ml of superfusate. Opiate containing buffer was 
superfused through the culture until 2-3 successive amino acid responses of similar 
amplitude were obtained after which the opiate was rinsed from the culture. Cells were 
often held for 3-4 h allowing up to 6 morphine concentrations to be tested on single 
neurons. The opioid peptide [D-Ala2]-Met-enkephalinamide was dissolved in ammo- 
nium acetate buffer (pH = 4.5) and then frozen in aliquots to be used in a single 
experiment. To prevent loss of peptide during superfusion, the medium contained 
0.1 ~ bovine serum albumin and 50/zg/ml bacitracin. 
Recording micropipettes were filled with 3 M potassium chloride; thus, chloride 
ions were injected into neurons, thereby altering the reversal potential for GABA and 
glycine responses from about --60 to about --20 mV. Since neurons were hyper- 
polarized to a potential o f - -80  mV, approximately 60 mV separated membrane 
potential from GABA and glycine reversal potentials and all amino acid responses were 
depolarizing. 
RESULTS 
Opiate alkaloids produced paroxysmal depolarizing events 
Spontaneous activity recorded from neurons in control medium consisted of 
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Fig. /.  Opiate alkaloids-induced paroxysmal electrical activity. Intracellular recordings of  spontane- 
ous activity during bath application of opiates. Action potentials were truncated due to the low 
frequency response of the pen recorder. Morphine (MORPH)-induced PDE were not antagonized by 
naloxone (NAL). Levorphanol (LEV) but not the L-t- enantiomer dextrorphan (DEX) nor [b-Ala2]- 
Met-enkephalinamide (DALA) produced PDE. Resting membrane potentials for figures A - F  were 
- -68 ,  - -60 ,  - -54 ,  - -52 ,  - - 6 0  and - -65  mV, respectively. 
randomly occurring action potentials and inhibitory and excitatory postsynaptic 
potentials (Fig. 1A). Fewer than 10 % of the neurons, however, showed a pattern of 
activity consisting of a burst of action potentials riding on a depolarization greater 
than 8 mV with a duration of 800 ms to 2 s. The incidence of these paroxysmal 
depolarizing events (PDE) 29 was increased by morphine (Fig. 1B). Naloxone, ad- 
ministered at 0.2-2 times the concentration of morphine, did not antagonize 
morphine-induced PDE, although it may have slightly attenuated the amplitude of the 
depolarizations (Fig. 1C). The opiate alkaloids produced PDE stereospecifically with 
100 ffM levorphanol inducing PDE in 60% of the neurons (Fig. 1D, Fig. 2), but the 
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Fig. 2. Opiate alkaloids increased the occurrence of PDE in a dose-dependent and stereospecific 
manner. Semllogarithmic plot of  the percentage of  neurons having PDE as a function of morphine 
concentration. At 100 ffM concentrations of  the enantiomers, levorphanol induced PDE with potency 
similar to morphine while dextrorphan was ineffective. Data were corrected for baseline occurrence of  
PDE in control medium. 
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L(+) enantiomer dextrorphan not altering spontaneous baseline activity (Figs. 1 E, 2). 
The opioid peptide [D-Ala2]-Met-enkephalinamide, did not increase the occurrence of 
PDE at concentrations of 200 nM to 20 ffM (Fig. 1F). The incidence of PDE was 
increased by morphine at concentrations of 10-125 ffM in a dose-dependent manner 
(Fig. 2). Morphine induced PDE in 50 ~o of neurons (EDs0), corrected for baseline 
occurrence of PDE in control medium, at a concentration of 25 #M (Fig. 2). 
Recordings were obtained from 16 to 27 neurons in two to three cultures at each 
morphine concentration. 
Morphine antagonized glycine- and GABA-mediated postsynaptic responses 
Morphine reversibly antagonized postsynaptic glycine (19 of 19 cells) and 
GABA (12 of 12 cells) responses (Fig. 3A). Glutamate responses (9 cells) were 
unaltered by morphine concentrations as high as 1.5 mM. Antagonism of glycine 
responses by morphine occurred over 1.5-750 ffM with an EDs0 of 35 #M (Fig. 4). 
Approximately ten-fold higher concentrations of morphine, 75/~M to 1.5 mM (EDs0 
---- 475 ffM), were required to antagonize GABA responses (Figs. 3A, 4). No changes 
in resting membrane potential or conductance were apparent during superfusion of 
opiate alkaloids through the cultures at concentrations which completely attenuated 
glycine and GABA response amplitudes. 
At a concentration of 20 ffM, the opioid peptide [D-Ala2]-Met-enkephalinamide 
did not affect the amplitude of postsynaptic glycine (n = 8), GABA (n = 6), or 
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Fig. 3. Opiate alkaloids depressed postsynaptic glycine and GABA but not glutamate responses. A. 
Dose-dependent actions of morphine on iontophoretically evoked glycine, GABA, and glutamate 
responses recorded from a single spinal cord neuron. Superfusion of the culture with medium 
containing 75/tM morphine attenuated glycine but not GABA or glutamate responses. Morphine at a 
concentration of 750 /tM also diminished GABA responses while glutamate responses were 
unaffected. B. The opioid peptide, [D-Ala~]-Met-enkephalinamide, did not affect amino acid 
responses. Superfusion of 20 ffM [o-AlaZ]-Met-enkephalinamide did not alter GABA, glutamate, or 
glycine responses, while application of 1.5 mM morphine to the same neuron attenuated glycine and 
GABA responses without altering glutamate responses. Recordings in this and subsequent figures 
were obtained with 3 M potassium chloride-filled micropipettes. Membrane potentials were hyper- 
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Fig. 4. Morphine attenuation of glycine and GABA responses was dose dependent. Morphine 
depressed glycine and GABA responses at concentrations exceeding 1.5 ffM (EDs0 = 35 ffM) and 75 
ffM (EDso -- 475 ffM), respectively. Glutamate responses were unaffected by morphine over the 
concentration range tested (1.5 ffM to 1.5 mM). Mean data from 3-9 neurons are given for each 
concentration tested. Bars represent standard error of the mean. 
glutamate (n = 8) responses (Fig. 3B). Although opioid peptide actions have been 
found to desensitize rapidly 21, it is unlikely that desensitization explains the observed 
lack of effect by [D-Ala~]-Met-enkephalinamide. Data were obtained from neurons in 
multiple (5) cultures, and amino acid responses were not antagonized in neurons which 
had not previously been exposed to the opioid peptide. Furthermore, application of 
1.5 mM morphine almost totally reduced GABA and glycine responses in neurons 
which had been unaffected by [D-AlaZ]-Met-enkephalinamide. 
To determine if opiate antagonism of glycine and GABA responses was 
stereospecific, 100 and 500 ffM concentrations of both levorphanol and dextrorphan 
were tested. Determination of relative levorphanol and dextrorphan potency in 
antagonizing the responses of neurons to glycine and GABA was obtained by testing 
equal concentrations of the enantiomers during each recording. Levorphanol anta- 
gonized glycine responses with potency similar to morphine while dextrorphan was less 
potent (Fig. 5, 6). Glycine responses were reduced by mean values of 72~  by 
levorphanol and 12 ~ by dextrorphan at enantiomer concentrations of 100 ffM (n -- 
5) (Fig. 6). The effects were dose-dependent with 500 ffM concentrations of levor- 
phanol and dextrorphan (n = 3) reducing glycine responses with mean values of 92 
and 64 ~,  respectively (Fig. 6). Glycine responses were significantly more reduced by 
levorphanol than dextrorphan at both 100 #M (paired t-test, P < 0.005, one-tailed) 
and 500 #M (paired t-test, P < 0.01, one-tailed) concentrations. At 100 #M 
concentrations, levorphanolwas at least 3 times more potent than dextrorphan in 
attenuating glycine responses (paired t-test, P < 0.05, one-tailed). The difference in the 
effectiveness of the enantiomers to attenuate glycine responses was not as marked at 
500 /~M concentrations, since levorphanol concentrations were approached which 
maximally depressed glycine responses. 
In contrast to effects on glycine responses, 100 #M concentrations of levor- 
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Fig. 5. Opiate alkaloid effects on glycine, but not GABA responses, were weakly stereospecific. The 
enantiomers, levorphanol and dextrorphan, were tested at concentrations of 100#M and 500ffM on a 
single neuron. At 100 ffM concentrations, levorphanol but not dextrorphan attenuated the glycine 
response and neither enantiomer affected the GABA response amplitude. The enantiomers at 500 #M 
concentrations were equipotent in attenuating GABA responses. The depolarization associated with 
iontophoresis of glycine during superfusion of 500 # M  levorphanol was a coupling artifact, not a 
glycine response. 
phanol and dextrorphan (n ----- 4) only minimally attenuated GABA response 
amplitude and did so with similar potencies; each depressed GABA responses with a 
mean of 5 % (Fig. 6). Levorphanol and dextrorphan at 500 ffM concentrations (n ----- 5) 
reduced GABA responses with mean values of 65 % and 58 %, respectively. Thus, the 
enantiomers were equipotent in reducing GABA response amplitude at 500 #M 
concentrations (paired t-test, P > 0.1 one-tailed). The effects of levorphanol and 
dextrorphan at 100 #M concentrations were not tested for a statistical difference since 
most neurons did not respond to either of the enantiomers at this concentration. 
Naloxone was tested for its ability to antagonize depression of glycine responses 
by morphine. Morphine at 75 ffM was chosen since it produced unambiguous but 
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Fig. 6. Opiate effects on glycine responses were weakly stereospecific. Mean glycine and GABA 
response amplitudes during superfusion of 100 ffM and 500 # M  concentrations of levorphanol and 
dextrorphan expressed as a percentage of response amplitude observed in control medium. Levor- 
phanol was more potent than dextrorphan in depressing glycine-responses at 100 # M  (n = 5) and 500 
/tM (n = 3) concentrations. GABA responses were depressed equipotently by the enantiomers at 100 
# M  (n = 4) and 500 # M  (n = 5) concentrations. Bars represent standard error of the mean. A 
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Fig. 7. Naloxone did not reverse morphine depression of glycine responses. Glycine response amplitude 
is plotted as a function of the volume superfused through the culture. Control glycine responses were 
about 13 mV (1). Superfusion of medium containing 75 ffM morphine attenuated glycine response 
amplitude to about 4 mV (2). Morphine-induced attenuation was not reversed by addition of either 50 
#M (3) or 200/~M (4) naloxone to the superfusion medium. Superfusion with control medium restored 
the control glycine amplitude (5). Application of 75 #M morphine again antagonized the glycine 
responses (6). 
incomplete diminution of glycine responses (mean reduction 70~) .  Addition of 
naloxone in concentrations of  50 #M to 1 mM to superfusion medium containing 75 
ffM morphine did not reverse depression of  glycine responses by morphine (n ~ 4) 
(Fig. 7). Subsequent rinsing of morphine and naloxone from the culture restored 
glycine responses to control amplitude. 
DISCUSSION 
Convulsant actions of opiates 
We have demonstrated that opiate alkaloids altered spontaneous neuronal 
activity, producing large amplitude, long-duration depolarizations with associated 
action potentials (PDE). Convulsants such as penicillin, pentylenetetrazol, bicuculline, 
and picrotoxin have been reported to produce a similar pattern of  activity in cultured 
spinal cord neurons 29. PDE may be an in vitro equivalent of paroxysmal depolarization 
shifts (PDS) observed during intracellular recording from neurons in cortical epileptic 
foci ~2,a3,4z and of  bursting recorded from spinal motoneurons following convulsant 
application 44. Therefore, opiate alkaloid-induced PDE in cultured spinal cord neurons 
might serve as a model of  morphine produced convulsions in vivo. 
To determine if opiate alkaloids produced PDE by interaction with opiate 
receptors, the effect was tested for stereospecificity, naloxone reversibility, and agonist 
properties of  the opioid peptides. The production of paroxysmal activity in the culture 
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was stereospecific, but neither naloxone-reversible nor [o-Ala2]-Met-enkephalina - 
mide-induced. These data indicate that the convulsant actions of opiates on cultured 
spinal cord neurons were not mediated by opiate receptors and, hence, were non- 
specific. This contrasts with findings implicating opiate receptors in seizure induction. 
Intracerebroventricular administration of the enkephalins or morphine has been 
reported to produce convulsions which were antagonized by high concentrations of 
naloxone19,20, 48. Opioid peptides have also been shown to induce naloxone-reversible 
PDS in hippocampal neurons zl. However, the opiate alkaloids have been reported to 
induce seizures by a non-opiate-receptor-mediated mechanism, suggested by the 
agonist actions of naloxone and the equipotency of opiate enantiomers as convul- 
santsaZ, 14. Thus, it is likely that opiate-mediated convulsions are produced by two 
mechanisms: an interaction of the opiate alkaloids and peptides with opiate receptors 
and by an action of the opiate alkaloids on neutral amino acid (glycine and GABA) 
receptors. 
Morphine antagonism of glycine and GABA responses 
We have found that morphine antagonized postsynaptic glycine and GABA, but 
not glutamate responses. These data are in agreement with observations in vivo that 
morphine antagonized glycine~,11,12,15,1~, 28 and, at higher iontophoretic currents, 
GABA 14-16 induced depression of unit firing. In contrast to our findings, morphine 
and the opioid peptides have been ~eported to depress glutamate excitatory actions on 
neuronal firing in a naloxone-reversible 1,17,28,53,55 and stereospecific 58 manner. Opiate 
depression of glutamate-induced firing was not reversed by naloxone in several other 
studies~6,~s,4L Our results suggest that opiates do not directly antagonize glutamate 
action on glutamate receptors, but do not rule out the possibility of an opiate receptor 
interaction with glutamate receptors. 
It is unlikely that antagonism of amino acid responses was mediated by opiate 
receptors since the effect was not produced by the opioid peptide [o-Ala2]-Met-enkeph - 
alinamide, antagonized by naloxone, or highly stereospecific. While levorphanol was 
three-fold more potent than dextrorphan in attenuating glycine responses, the observed 
difference was 10-100 times less than predicted for an opiate-receptor-mediated 
phenomenon3,5, 40. Furthermore, concentrations of morphine required for antagonism 
of glycine- and GABA-mediated responses were higher than expected for an opiate- 
receptor-mediated effect. High levels of analgesia occui at 1/~M brain concentrations of 
morphine22, 35, whereas a similar concentration of morphine attenuated glycine 
response amplitude by less than 10~. In preparations where opiate concentration 
could be accurately determined and correlated with a physiological action, opiates 
have been found to exert effects in the low nanomolar concentration range zs,39,49,52. 
therefore, there is a 100-1000-fold difference in potency between morphine antago- 
nism of inhibitory amino acid responses and opiate-receptor-mediated effects. These 
data are consistent with antagonism of inhibitory amino acid responses underlying 
opiate-mediated convulsions and not analgesia since 100-1000 times the analgesic dose 
of morphine is required for the induction of seizures 41,47. 
Morphine antagonized postsynaptic glycine and GABA responses in the absence 
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of an effect on resting membrane potential or conductance. Both amino acids increase 
membrane conductance to chloride ions 2. Therefore, morphine might simultaneously 
depress neuronal responsiveness to GABA and glycine by binding to a site which 
modulates chloride channel conductance. However, such a mechanism is unlikely 
since GABA and glycine responses were depressed with differing potency by the 
opiates: the dose response curves for depression of GABA and glycine responses were 
separated by one log unit, and antagonism of glycine but not GABA responses was 
stereospecific. Furthermore, opiate alkaloids have been shown to displace pH]GABA 
and pH]strychnine with low affinity from GABA and glycine receptors14, 5a, respec- 
tively. Thus, it is likely that opiate alkaloids bind to glycine and GABA receptors as do 
strychninO ° and bicuculline 7,8, rather than to chloride channels. 
Antagonism of inhibitory amino acids: correlation with paroxysmal activity 
Morphine produced PDE over a concentration range similar to that producing 
antagonism of glycine responses (Fig. 8), while morphine dose-response curves for 
production of PDE and antagonism of GABA responses were separated by one log 
unit with PDE occurring at lower morphine concentrations. Since GABA and glycine 
are inhibitory transmitters with a ubiquitous distribution in the central nervous 
systemm24,2n, it is likely that alteration of  the actions of these amino acids would have 
profound effects on neuronal activity. Indeed, a decrease in amino acid mediated 
postsynaptic inhibition has been proposed as a mechanism of  convulsant action zm34. 
The good correlation between antagonism of  postsynaptic glycine responses and 
increased PDE in spinal cord neurons was not surprising since glycine is the principal 
inhibitory transmitter in spinal cord 50. Our data suggest that glycine-mediated 
inhibition must be reduced by approximately 20 ~ for the production of paroxysmal 
activity in the culture. At supraspinal levels, GABA is the principle inhibitory 
transmitter 27 and, therefore, the dose-response curve for morphine-mediated PDE 
might be expected to be shifted to the right. 
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Fig. 8. Morphine attenuation of glycine responses and induction of PDE occurred over similar 
concentration ranges. Glycine responses were approximately 20% attenuated at threshold morphine 
concentration for PDE. EDs0s for attenuation of glycine responses and induction of PDE were 35 pM 
and 25 #M, respectively. 
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